More on AMGN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-7.0% Growth)
- Ratings (4.7 Score)
- Holders
- Dividends (2.7% Yield)
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/4/26)
- M&A (N/A)
- M&A (12/31/22 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

AMGN Income Statement

Click line-items for a historical chart and %
Product sales 5.52B
Other revenues 295M
Total revenues 5.81B
Cost of sales (excludes amortization of certain acquired intangible assets presented below)
Research and development 990M
Selling, general and administrative 1.24B
Amortization of certain acquired intangible assets
Other charges 23M
Total operating expenses 3.28B
Operating income 2.53B
Interest expense, net 325M
Interest and other income, net 216M
Income before income taxes 2.42B
Provision for income taxes 401M
Net income 2.02B
Basic 2.7
Diluted 2.68
Basic 747M
Diluted 753M